An Analysis of Xpert Test for Diagnosing Maxillofacial Tuberculosis
- 24 September 2021
- journal article
- research article
- Published by Springer Nature in Journal of Maxillofacial and Oral Surgery
- Vol. 22 (3) , 533-537
Abstract
Background Maxillofacial tuberculosis is a diagnostic challenge for surgeons. The aim of this study was to present a detailed analysis of Xpert test in diagnosing maxillofacial tuberculosis and to analyse the accuracy of Xpert test results for various tissues of maxillofacial region. Materials and Methods In this cross-sectional study, patients were selected randomly from outpatient department. The patients who had clinical picture and differential diagnosis highly suggestive of maxillofacial tuberculosis were included. Patients were divided into three different groups depending upon the site of involvement. The samples collected from the patients were further subdivided depending upon the type of specimen. Patients were screened first by routine tests, and the negative cases were followed by Xpert test for tuberculosis. Results A total of 54 patients were enrolled in the study, 13 patients were found to be positive for maxillofacial tuberculosis on routine screening tests for tuberculosis, and 41 tested negative on routine test and were evaluated further through Xpert test. Specimens from bone (n12), soft tissue and skin biopsy (n15) and aspirates from lymph nodes (n14) were obtained and tested. Twenty-one samples were found to be positive, and 20 were negative upon Xpert testing. There was a statistically significant difference seen between the test groups (p < 0.01) with higher frequency of negative results in routine test. The p value for various specimens containing pus, biopsies and aspirates was 0.045, 0.023 and 0.067, respectively. Conclusion Xpert test is more accurate when compared to routine test for diagnosing maxillofacial tuberculosis. Although accuracy of Xpert test is better for pus and biopsy samples in the specimens from bone and soft tissue, it gives poor accuracy for aspirated cells. The aspirates from lymph nodes were more susceptible for false negative test.Keywords
This publication has 10 references indexed in Scilit:
- Index-TB GuidelinesIndian Journal of Medical Research, 2017
- Tuberculosis 2015: Burden, Challenges and Strategy for Control and EliminationInfectious Disease Reports, 2016
- Diagnostic performance of the Xpert MTB/RIF assay for tuberculous lymphadenitis on fine needle aspirates from EthiopiaTuberculosis, 2014
- Diagnostic Accuracy of Xpert MTB/RIF for Extrapulmonary Tuberculosis Specimens: Establishing a Laboratory Testing Algorithm for South AfricaJournal of Clinical Microbiology, 2014
- Early tuberculosis treatment monitoring by Xpert® MTB/RIF: Figure 1–European Respiratory Journal, 2012
- Orofacial Tuberculosis—A 16-Year Experience With 46 CasesJournal of Oral and Maxillofacial Surgery, 2012
- Xpert MTB/RIF: a New Pillar in Diagnosis of Extrapulmonary Tuberculosis?Journal of Clinical Microbiology, 2011
- Evaluation of the Analytical Performance of the Xpert MTB/RIF AssayJournal of Clinical Microbiology, 2010
- A clinical review of 128 cases of head and neck tuberculosis presenting over a 10-year period in Bradford, UKThe Journal of Laryngology & Otology, 2006
- Tuberculous lymphadenitis in childhood: The significance of anonymous mycobacteriaBritish Journal of Surgery, 1962